Ivermectin Regimen for Crusted Scabies
For crusted scabies, use oral ivermectin 200 mcg/kg on days 1,2,8,9, and 15, combined with daily topical permethrin 5% cream (full-body application for 7 days, then twice weekly until cure), with additional ivermectin doses on days 22 and 29 for severe cases. 1
Core Treatment Protocol
The CDC guidelines explicitly state that crusted scabies requires combination therapy because single-agent treatment—whether topical or oral ivermectin alone—frequently fails 1. This aggressive approach is necessary because crusted scabies involves massive mite burdens (thousands to millions of mites versus 10-15 in ordinary scabies) and occurs in immunocompromised hosts.
Oral Ivermectin Dosing Schedule
- Standard regimen: 200 mcg/kg on days 1,2,8,9, and 15 1
- Severe cases: Add doses on days 22 and 29 1
- Administration: Take with food to increase bioavailability and epidermal penetration 1
Concurrent Topical Therapy
Apply permethrin 5% cream (or 5% benzyl benzoate as alternative):
- Full-body application daily for 7 days
- Then twice weekly until discharge or cure 1
Clinical Reasoning
This intensive regimen addresses several key challenges:
Why multiple ivermectin doses? Ivermectin has limited ovicidal activity—it doesn't kill eggs effectively 1. The closely-spaced initial doses (days 1-2,8-9) target newly hatched larvae before they mature and reproduce. The thick, hyperkeratotic skin in crusted scabies also impairs drug penetration, necessitating repeated dosing 1.
Why combination therapy? Topical agents cannot penetrate the thick crusts adequately when used alone, while oral ivermectin alone misses mites in hyperkeratotic areas 1. The combination provides complementary mechanisms of mite eradication.
Important Caveats
Safety Considerations
- Avoid in severe liver disease: Multiple ivermectin doses have unknown safety in this population 1
- Renal impairment: No dose adjustment needed 1
- Avoid lindane: Neurotoxicity risk is unacceptable with denuded skin in crusted scabies 1
Treatment Failures and Resistance
Research evidence shows variable success rates. One study found only 8/20 patients achieved complete initial response with 1-3 doses, with recurrence common even after apparent cure 2. Another case required 7 doses for resolution after failing conventional therapy 3. This underscores why the CDC recommends the extended 5-7 dose regimen rather than the 2-dose schedule used for ordinary scabies.
Critical pitfall: Nail scabies may not respond to oral ivermectin and requires occlusive topical treatment 4. Examine nails carefully and consider prolonged occlusive dressing with topical scabicides if nail involvement is present.
Adjunctive Measures
- Keratolytic agents: Use to remove thick crusts and improve drug penetration 4, 2
- Environmental decontamination: Machine-wash/dry bedding and clothing on hot cycle or remove from body contact for 72 hours 1
- Contact treatment: Treat all household and close contacts simultaneously to prevent reinfection 1
Follow-Up Strategy
Symptoms may persist up to 2 weeks after successful treatment due to allergic dermatitis 1. However, persistence beyond 2 weeks warrants:
- Microscopic examination for live mites
- Consideration of treatment failure versus reinfection
- Retreatment with alternative or extended regimen if live mites detected 1
Monitor closely: Crusted scabies patients are highly contagious and can trigger institutional outbreaks 1. Isolation precautions should continue until cure is confirmed.
The evidence consistently supports this aggressive multi-dose approach over the standard 2-dose regimen used for ordinary scabies, given the high mite burden, impaired host immunity, and substantial treatment failure rates with less intensive protocols.